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rtemisinin resistance in falciparum malaria
. Dondorp
Mahidol University, Bangkok, Thailand
Artemisinin combination therapy (ACT) is the WHO recom-
ended ﬁrst line therapy for uncomplicated falciparum malaria in
ost malaria endemic countries and parenteral artesunate is the
est drug to treat severe falciparum malaria. It is therefore alarm-
ng that reduced sensitivity of P. falciparum to the artemisinins has
merged on the Thai-Cambodian border region and more recently
n theThai-Myanmarborder. This partial resistance to artemisinins
s characterizedby severelydelayedparasite clearance rates invivo.
his results in amuchhigher residual parasite biomass after a 3-day
ourse with ACT which renders the partner drug more vulnerable
o development of resistance. Indeed, higher failure rates with ACT
ave now also been reported in the same region. Recognizing the
rgency of the problem, a containment programhas been launched
y the WHO in collaboration with the national malaria control pro-
rams of Cambodia and Thailand as well as other stakeholders. The
ontainment strategy critically depends on whether artemisinin
esistance has emerged or spread in other regions, and a multi-
ational study addressing this is under way. These studies require
ccurate assessment of the parasite clearance curve, since molec-
lar markers or sensitive in-vitro tests for artemisinin resistance
re currently lacking. However, using several approaches there has
een made important progress towards the identiﬁcation of the
enetic basis of artemisinin resistance. Also better in-vitro tests are
eing developed. The optimal treatment of artemisinin resistant
alciparum malaria will have to be deﬁned, in the context of a lim-
tednumber of available antimalarial drugs. Containing artemisinin
esistance will require malaria eradication from the region, but
any of the potential tools to achieve this have not been evaluated.
athematical modeling of the different containment scenarios can
e an important tool to guide these efforts.
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rogress towards effective malaria vaccination
. Ockenhouse
Malaria Vaccine Branch, Silver Spring, MD, USANo abstract received from presenter.
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A future without malaria
Y. Yuthavong
BIOTEC, National Science and Technology Development Agency,
Thailand Science Park, Pathumtani, Thailand
Malaria eradication has been adopted as ultimate goal by
Malaria Forum, 2007 (Bill and Melinda Gates Foundation) and
endorsed by WHO, Roll Back Malaria and other organizations. As
the global community mounts unprecedented efforts to achieve
the ambitious goal, the difﬁculties lie in the fact thatmalaria is both
medical/scientiﬁc and socioeconomic/ecological problem. Control
and eventual eradication strategies must therefore adopt not
only technological tools, but also socio-economic and eco-health
approaches. The tools, ranging from drugs, vaccines, diagnostics,
water management and vector control, must be used in conjunc-
tion with measures on population migration, livelihood, and public
awareness. Analysis of probability of success and impact of the var-
iousmeasures should help in prioritization and resource allocation.
It is essential that collaboration in both R&D and implementation
be made between the endemic, mostly developing, countries and
the high-income countries where technological tools are shaped.
Total success will take decades of prolonged efforts and require
huge ﬁnancial resources. Success in eliminating malaria as global
public health threat is an attractive alternative, both in terms of
cost-effectiveness and ecological outcome.
http://dx.doi.org/10.1016/j.ijid.2012.05.109
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Update on management of severe malaria
S. Mishra
Ispat General Hospital, Rourkela, Orissa, India
Management of severe malaria requires a multi-disciplinary
approach, as multi-organ dysfunction is very common. The com-
plications may occur simultaneously or sequentially. For example,
acute kidney injury (AKI) may occur along with cerebral malaria
(CM) or may appear when the patients have fully recovered
from CM. Common complications in severe malaria are: Cerebral
malaria, multiple convulsions, severe anemia, acute kidney injury,
respiratory distress syndrome, hypoglycemia, DIC, Severe jaundice,
etc.
Several recent studies on pathogenesis indicate that sequestra-
tion due to pRBC and non pRBC lead to clogging which in turn
compromise microcirculation.
Beyond parasite diagnosis, there is a need to diagnose and mon-
itor organ involvement. This will be possible by utilizing Point of
